ERBB2 and breast cancer: However, the nodal status of patients with these small tumors was not reported by the authors, therefore no definitive conclusions can be drawn on the efficacy of trastuzumab in the adjuvant therapy for HER2 positive pT1a-b pN0 breast cancer.